A small group aerobic exercise programme that reduces body weight is feasible in adults with severe chronic schizophrenia: A pilot study

Disability and Rehabilitation

Volumn 33, Issue 13-14, 2011, Pages 1222-1229

  Dodd, Karen J ^a   Duffy, Sean ^b   Stewart, Jan A ^c   Impey, Jennifer ^d   Taylor, Nicholas ^a,e  

^a LA TROBE UNIVERSITY   (Australia)

^b EW Tipping Foundation   (Australia)

^c Ballarat Health   (Australia)

^d CGU Workers Compensation   (Australia)

^e EASTERN HEALTH   (Australia)

Author keywords

exercise; physical activity; Schizophrenia

Indexed keywords

ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; EXERCISE; FEASIBILITY STUDY; FEMALE; FITNESS; HEALTH PROMOTION; HUMAN; MALE; MENTAL HEALTH; MIDDLE AGED; OBESITY; PILOT STUDY; PSYCHOSIS; SCHIZOPHRENIA; WEIGHT REDUCTION;

ADULT; CHRONIC DISEASE; EXERCISE; FEASIBILITY STUDIES; FEMALE; HEALTH PROMOTION; HUMANS; MALE; MENTAL HEALTH; MIDDLE AGED; OVERWEIGHT; PHYSICAL FITNESS; PILOT PROJECTS; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; WEIGHT LOSS;

EID: 79957586063     PISSN: 09638288     EISSN: 14645165     Source Type: Journal    
DOI: 10.3109/09638288.2010.526162     Document Type: Article

References (36)

1. Brown S, Birtwistle J, Roe L, Thompson C. The unhealthy lifestyle of people with schizophrenia. Psychol Med 1999;29:697-701. (Pubitemid 29261358)
2. Allison DB, Fontaine KR, HeoM,Mentore JL, Cappelleri JC, Chandler LP, Weiden PJ, Cheskin LJ. The distribution of body mass index among individuals with and without schizophrenia. J Clin Psychiatry 1999;60:215-220. (Pubitemid 29193917)
3. McCreadie RG. Diet, smoking and cardiovascular risk in people with schizophrenia. Br J Psychiatry 2003;183:534-539. (Pubitemid 37533200)
4. Dixon LB. Health, medical comorbidities, and diabetes in schizophrenia. Drug Benefit Trends 2003;15 (Suppl B):6-11. (Pubitemid 36575524)
5. von Hausswolff-Juhlin Y, Bjartveit M, Lindstrom E, Jones P. Schizophrenia and physical health problems. Acta Psychiatr Scand Suppl 2009;438:15-21.
6. Faulkner G, Biddle S. Exercise as an adjunct treatment for schizophrenia: A review of the literature. J Mental Health 1999;8:441-457. (Pubitemid 29515375)
7. Ellis N, Crone D, Davey R, Grogan S. Exercise interventions as an adjunct therapy for psychosis: A critical review. Br J Clin Psychol 2007;46 (Part 1):95-111. (Pubitemid 46332280)
8. Pelletier JR, Nguyen M, Bradley K, Johnsen M, McKay C. A study of a structured exercise programme with members of an ICCD Certified Clubhouse: Programme design, benefits, and implications for feasibility. Psychiatric Rehabil J 2005;29:89-96. (Pubitemid 41483751)
9. McDevitt J, Wilbur J, Kogan J, Briller J. A walking programme for outpatients in psychiatric rehabilitation: Pilot study. Biol Res Nurs 2005;7:87-97. (Pubitemid 44289587)
10. Marzolini S, Jensen B, Melville P. Feasibility and effects of a group-based resistance and aerobic exercise programme for individuals with severe schizophrenia: A multidisciplinary approach. Mental Health Phys Activity 2009;2:29-36.
11. Acil AA, Dogan S, Dogan O. The effects of physical exercises to mental state and quality of life in patients with schizophrenia. J Psychiatric Mental Health Nurs 2008;15:808-815.
12. Faulkner G, Cohn T, Remington G. Interventions to reduce weight gain in schizophrenia. Cochrane Database Syst Rev 2007;1:CD005148.
13. Poulin MJ, Chaput JP, Simard V, Vincent P, Bernier J, Gauthier Y, Lanctot G, Saindon J, Vincent A, Gagnon S, Tremblay A. Management of antipsychotic-induced weight gain: Prospective naturalistic study of the effectiveness of a supervised exercise. Aust New Zealand J Psychiatry 2007;41: 980-989. (Pubitemid 350120827)
14. Wu MK, Wang CK, Bai YM, Huang CY, Lee SD. Outcomes of obese, clozapine-treated inpatients with schizophrenia placed on a six-month diet and physical activity programme. Psychiatric Services 2007;58:544-550.
15. Rege S. Antipsychotic induced weight gain in schizophrenia: Mechanisms and management. Aust NZ J Psychiatry 2008;42: 369-381. (Pubitemid 351877210)
16. Archie S, Wilson JH, Osborne S, Hobbs H, McNiven J. Pilot study: Access to fitness facility and exercise levels in Olanzapine- treated patients. Can J Psychiatry 2003;48:628-632. (Pubitemid 37429468)
17. Beebe LH, Tian L, Morris N, Goodwin A, Allen SS, Kuldau J. Effects of exercise on mental and physical health parameters of persons with schizophrenia. Issues Ment Health Nurs 2005;26:661-676. (Pubitemid 41022038)
18. Skrinar G S, Huxley NA, Hutchinson DS, Menninger E, Glew P. The role of a fitness intervention on people with serious psychiatric disabilities. Psychiatric Rehabil J 2005;29: 122-127. (Pubitemid 41483755)
19. Hutchinson DS. Structured exercise for persons with serious psychiatric disabilities. Psychiatric Services 2005;56:353-354. (Pubitemid 40333571)
20. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV), 4th ed. Text Revision. Washington, DC: American Psychiatric Association; 2000.
21. American College of Sports Medicine. Position stand: The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness, and flexibility in healthy adults. Med Sci Sports Exer 1998;30: 975-991.
22. Golding LA, Myers CR, Sinning WE. Y's way to physical fitness, 3rd ed. Champaign, IL: Human Kinetics; 1989.
23. Beekley MD, Brechue WF, deHoyos DV, Garzarella L, Werber-Zion G, Pollock ML. Cross-validation of the YMCA submaximal cycle ergometer test to predict VO2max. Res Q Exerc Sport 2004;75:337-342.
24. Tappen RM, Roach KE, Buchner D, Barry C, Edlestein J. Reliability of physical performance measures in nursing home residents with Alzheimer's disease. J Gerontol A Biol Med Sci 1997;52:M52-M55. (Pubitemid 27034830)
25. Kay SR, Fiszbean A, Opler LA. Positive and negative syndrome scale (PANSS) manual. Toronto: Multi-Health Systems; 1992.
26. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bull 1987;13:261-276. (Pubitemid 18039085)
27. Lindenmayer JP, Kay SR, Opler L. Positive and negative subtypes in acute schizophrenia. Comprehensive Psychiatry 1984;25:455-464. (Pubitemid 14087426)
28. Kay SR, Opler LA. L-dopa in the treatment of negative schizophrenic symptoms: A single-subject experimental study. Int J Psychiatry Med 1985-1986;15:293-298. (Pubitemid 16196538)
29. Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for the Treatment of Schizophrenia and Related Disorders Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders. Aust N Z J Psychiatry 2005;39:1-30.
30. Lehman AF, Lieberman JA, Dixon LB, McGlashan TH, Miller AL, Perkins DO, Kreyenbuhl J. Practice guideline for the treatment of patients with schizophrenia, 2nd ed. 2004. http: //www.psychiatry online.com/pracGuide/ loadGuideline Pdf.aspx?file=Schizophrenia2e-Inactivated-04-16-09. Accessed 10 July 2009.
31. Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Moller HJ. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Long-term treatment of schizophrenia. The World J Biol Psychiatry 2006;7:5-/40. (Pubitemid 43878525)
32. Shiner B, Whitley R, Van Citters AD, Pratt SI, Bartels SJ. Learning what matters for patients: Qualitative evaluation of a health promotion programme for those with serious mental illness. Health Promotion Int 2008;23:275-282.
33. Ussher M, Stanbury L, Cheeseman V, Faulkner G. Physical activity preferences and perceived barriers to activity among persons with severe mental illness in the United Kingdom. Psychiatric Services 2007;58:405-408. (Pubitemid 46480060)
34. American Diabetes Association, the American Psychiatric Association, the American Association of Clinical Endocrinologists, and the North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 2004;27: 596-601.
35. Wilding J. Science, medicine, and the future: Obes Treatment. BMJ 1997;315:997-1000.
36. Daly PA, Solomon CG, Manson JE, editors. Risk modification in the obese patient. New York: Oxford University Press; 1996.